GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
Main Authors: | Xue, Y, Wu, G, Liao, Y, Xiao, G, Ma, X, Zou, X, Zhang, G, Xiao, R, Wang, X, Liu, Q, Long, D, Yang, J, Xu, H, Liu, F, Liu, M, Xie, K, Huang, R |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007226/ |
Similar Items
-
Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
by: Zhang, Luan-Jing, et al.
Published: (2014) -
GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
by: Li, Huan, et al.
Published: (2012) -
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
by: Song, L. J., et al.
Published: (2016) -
GOLPH3L antagonizes GOLPH3 to determine Golgi morphology
by: Ng, Michelle M., et al.
Published: (2013) -
High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
by: Wang, Jian-Hua, et al.
Published: (2012)